LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Assets, Gross
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Deferred Tax Assets, Gross of $106.78 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-02-27
- 2025-12-31: Deferred Tax Assets, Gross $106.78M.
- 2024-12-31: Deferred Tax Assets, Gross $96.34M.
- 2023-12-31: Deferred Tax Assets, Gross $103.76M.
- 2022-12-31: Deferred Tax Assets, Gross $110.97M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2025-12-31 | $106.78M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $96.34M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $103.76M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $110.97M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $113.11M 10-K · filed 2023-02-28 | $123.19M 10-K · filed 2022-02-28 |
| 2020-12-31 | $108.88M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $185.72M 10-K · filed 2021-02-24 | $184.12M 10-K · filed 2020-02-27 |
| 2018-12-31 | $102.96M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $143.04M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $213.08M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $217.64M 10-K · filed 2017-02-28 | $245.12M 10-K · filed 2016-02-26 |
| 2014-12-31 | $256.40M 10-K · filed 2016-11-14 | $264.28M 10-K · filed 2014-12-01 |
| 2013-12-31 | $264.28M 10-K · filed 2015-02-23 | |
| 2012-12-31 | $270.01M 10-K/A · filed 2014-12-12 | |
| 2011-12-31 | $230.98M 10-K · filed 2013-03-14 |